Introduction {#H1-1-ZOI190324}
============

The prevalence of dementia has increased,^[@zoi190324r1]^ with rapid increases in the elderly population. Dementia is associated with a higher risk of mortality, higher health care costs, and disability. Current treatment strategies only ameliorate symptoms and do not change the disease course. Identification of patients at risk of dementia is critical for preventing an impending dementia epidemic. Hearing loss (HL) has recently been recognized as a risk factor for dementia. The risk of HL increases with age and is associated with lower scores on tests of memory and a higher risk of incident all-cause dementia.^[@zoi190324r2],[@zoi190324r3]^ Hearing loss includes peripheral hearing impairment and central auditory dysfunction; both are associated with accelerated cognitive decline, cognitive impairment, and incident dementia.^[@zoi190324r2],[@zoi190324r4],[@zoi190324r5],[@zoi190324r6]^ Evidence suggests that even mild levels of HL increase the long-term risks of cognitive decline and dementia.^[@zoi190324r2],[@zoi190324r4],[@zoi190324r7],[@zoi190324r8],[@zoi190324r9]^ Hearing loss in older adults may play a role in social isolation, depression, disability, lower quality of life, and risk of dementia^[@zoi190324r10]^; however, HL is a possible biomarker of and modifiable risk factor for cognitive decline, cognitive impairment, and dementia.^[@zoi190324r11]^ A meta-analysis^[@zoi190324r12]^ stated that 65% of the risk factors for dementia are hereditary or genetic, which means they are not modifiable; however, 35% of the factors can be modified. Moreover, the adjusted population-attributable fraction of HL was calculated to be 9.1%; HL had the highest population-attributable fraction compared with other identified risk factors such as hypertension, obesity, depression, types 1 and 2 diabetes, and smoking. Thus, this longitudinal cohort study aimed to examine the association between HL and dementia.

Methods {#H1-2-ZOI190324}
=======

The institutional review board of National Taiwan Normal University approved this study. Written informed consent from the study patients was waived by the institutional review board because data were collected from the National Health Insurance Research Database (NHIRD), which consists of deidentified secondary data released for research purposes. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology ([STROBE](http://www.equator-network.org/reporting-guidelines/strobe/)) reporting guideline.

Data Sources {#H2-1-ZOI190324}
------------

This cohort study was conducted using data from the NHIRD.^[@zoi190324r13]^ From this database, we collected data on outpatient care, inpatient care, ambulatory care, dental services, and prior medical conditions from January 1, 1997, through December 31, 2013. The National Health Insurance (NHI) program of Taiwan was established in 1995; it is a single-payer insurance system operated by the government that ensures the health of the entire nation and prevents social problems caused by poverty and disease. As of 2014, 99.9% of Taiwan's population was enrolled in the NHI program.

Study Design and Population {#H2-2-ZOI190324}
---------------------------

We conducted a population-based retrospective matched cohort study. Codes from *International Classification of Diseases, Ninth Revision, Clinical Modification* (*ICD-9-CM*) were used for disease diagnosis. Hearing loss was defined according to the *ICD-9-CM* codes 389 and A241 and included conductive, sensorineural, and mixed conductive, sensorineural, and unspecified HL. All medical claims between 1997 and 2013 containing these codes were obtained from the NHIRD for further analysis. Hearing loss with a duration of more than 1 year was considered, and at least 2 outpatient visits or any inpatient diagnosis was required. Patients newly diagnosed with HL from January 1, 2000, through December 31, 2011, were included in the exposed group (HL group); persons who were diagnosed with HL from 1997 through 1999 were excluded. Thus, 8135 patients newly diagnosed with HL without a dementia diagnosis before the index date were included. These exposed patients were compared with 8135 sex-, age-, residence-, and insurance premium--matched unexposed individuals (non-HL group) by exact matching. The index date was calculated by adding 365 days to the HL diagnosis date, and this date was assigned to the respective matched unexposed individuals, who were NHI enrollees without any HL or dementia diagnosis before the index date. Dementia (*ICD-9-CM* codes 290, 294.1, 331.0, 331.82, and A210) constituted the study outcome (eFigure 1 in the [Supplement](#note-ZOI190324-1-s){ref-type="supplementary-material"}). Dementia was considered as an inpatient diagnosis or a diagnosis for outpatient services from the HL index date (HL diagnosis date plus 365 days).

Potential Confounders {#H2-3-ZOI190324}
---------------------

To better understand the association between HL and dementia, several potential confounders were included in this study. We defined potential confounders based on medical claims data from the NHIRD from January 1, 1997, to the index date. Demographic data included age, sex, residence, and insurance premium. The following general physical health data related to dementia were also collected: coronary artery disease (*ICD-9-CM* codes 410-415), cerebrovascular disease (*ICD-9-CM* codes 362.34 and 430-438), chronic obstructive pulmonary disease (*ICD-9-CM* codes 491, 492, 494, and 496), types 1 and 2 diabetes (*ICD-9-CM* codes 250 and 251), chronic kidney disease (*ICD-9-CM* codes 580-589), hypertension (*ICD-9-CM* codes 401-405), hyperlipidemia (*ICD-9-CM* code 272), anxiety (*ICD-9-CM* codes 300.0, 300.01, 300.02, 300.2, 300.21, 300.23, and 300.3), depression (*ICD-9-CM* codes 311, 296.2, 296.3, 296.82, 293.83, and 300.4), alcohol-related illness (*ICD-9-CM* codes 291, 303, 305.0, 571.0, 571.1, 571.2, 571.3, 790.3, A215, and V11.3), head injury (*ICD-9-CM* codes 800-804, 850-852, 853.1, 853.2, 854.0, 854.1, A290-291, and A470), rheumatoid arthritis (*ICD-9-CM* code 714), and asthma (*ICD-9-CM* code 493). The comorbidities included were required to be more than 1 year in duration and to have at least 2 outpatient visits or any inpatient diagnosis. Finally, the hospitalization length was included.

Statistical Analysis {#H2-4-ZOI190324}
--------------------

Data were analyzed from January 1, 2000, to December 31, 2013. The first dementia diagnosis of each person within the study period was used to calculate the risk of dementia during specific time intervals. The risk of dementia during the follow-up period was calculated using survival analysis. Follow-up was conducted from the index date to withdrawal from the NHI program or December 31, 2013, whichever occurred first. This study included incident dementia diagnosed from the index date (HL diagnosis date plus 365 days) to December 31, 2013. Multivariate Cox proportional hazards regression models adjusted for covariates were used to determine the associations of HL with dementia. The false discovery rate (FDR) and hazard ratios (HRs) with 95% CIs were calculated. False discovery--adjusted *P* values were used to avoid the inflation of false-positive findings. The model was applied for analyzing the entire study population. Subsequently, subgroups were formed according to sex and age, and the model was tested on these subgroups. Data analysis was performed with 2-sided tests using SAS, version 9.4 (SAS Institute Inc). *P* \< .05 indicated significance.

Sensitivity Analyses {#H2-5-ZOI190324}
--------------------

To validate the robustness of the main study findings, we performed sensitivity analyses. Through subgroup analysis, the association of HL subgroups with dementia risk was evaluated. Furthermore, we used propensity score matching to control for sampling bias. Propensity scores represent patients' probability of dementia incidence, and the scores were determined using a multivariate logistic regression model. The potential confounders used to calculate propensity scores included sex, age, residence, insurance premium, coronary artery disease, cerebrovascular disease, chronic obstructive pulmonary disease, diabetes, chronic kidney disease, severe liver disease, hyperlipidemia, anxiety, depression, alcohol-related illness, head injury, rheumatoid arthritis, asthma, and hospitalization length. The index year was defined as the year of the first HL diagnosis, and the index year was randomly selected for patients without HL. Using the estimated propensity scores, the HL and non-HL groups were matched at a ratio of 1:1 as closely as possible within each matched index year. Thus, the index year was the same between patients with HL and propensity score--matched individuals without HL. For balance diagnostics, the standardized difference was used to compare the mean of the binary variable between the HL and non-HL groups in propensity score--matched and nonmatched samples. A standardized difference of less than 0.1 indicated a negligible difference in the prevalence of a covariate between the HL and non-HL groups.^[@zoi190324r14]^

Results {#H1-3-ZOI190324}
=======

Population Characteristics {#H2-6-ZOI190324}
--------------------------

A total of 16 270 participants were included, of whom 9286 (57.1%) were men and 6984 (42.9%) were women (mean \[SD\] age, 65.2 \[11.1\] years). The exposed and unexposed groups included, respectively, 8135 patients with newly diagnosed HL (aged ≥45 years) and 8135 sex-, age-, residence-, and insurance premium--matched individuals without HL. Descriptions and a comparison of the groups' characteristics are presented in [Table 1](#zoi190324t1){ref-type="table"} and eFigure 2 in the [Supplement](#note-ZOI190324-1-s){ref-type="supplementary-material"}. Of patients with HL, 4643 (57.1%) were men, 3492 (42.9%) were women, and mean (SD) age was 65.2 (11.2) years. Urban residents constituted 5748 (70.7%), and 5179 (63.7%) were insurance premium dependent, had a low income, or had an insurance premium of less than NT\$20 000. Coronary artery disease (2098 \[25.8%\] vs 1498 \[18.4%\]), cerebrovascular disease (1281 \[15.7%\] vs 909 \[11.2%\]), chronic obstructive pulmonary disease (1983 \[24.4%\] vs 1338 \[16.4%\]), diabetes (1801 \[22.1%\] vs 1460 \[17.9%\]), chronic kidney disease (714 \[8.8%\] vs 517 \[6.4%\]), hypertension (3955 \[48.6%\] vs 3482 \[42.8%\]), hyperlipidemia (2546 \[31.3%\] vs 1897 \[23.3%\]), anxiety (1762 \[21.7%\] vs 974 \[12.0%\]), depression (547 \[6.7%\] vs 282 \[3.5%\]), head injury (565 \[6.9%\] vs 378 \[4.6%\]), rheumatoid arthritis (199 \[2.4%\] vs 116 \[1.4%\]), and asthma (909 \[11.2%\] vs 719 \[8.8%\]) were more commonly observed in patients with HL than in the non-HL group (*P* \< .001). The mean number of hospital admission days was higher in the HL group than in the non-HL group (2.78 \[95% CI, 2.52-3.05\] vs 1.83 \[95% CI, 1.55-2.09\] days; 2-tailed *t* test, *P* \< .001).

###### Characteristics of Enrollees With HL and Their Matched Controls in Taiwan

  Characteristic                                                                             HL Group           Non-HL Group[^a^](#zoi190324t1n1){ref-type="table-fn"}   *P* Value[^b^](#zoi190324t1n2){ref-type="table-fn"}
  ------------------------------------------------------------------------------------------ ------------------ -------------------------------------------------------- -----------------------------------------------------
  Sex, No. (%)                                                                                                                                                           
  Male                                                                                       4643 (57.1)        4643 (57.1)                                              Exact match
  Female                                                                                     3492 (42.9)        3492 (42.9)                                              
  Age, mean (SD), y                                                                          65.2 (11.2)        65.1 (11.1)                                              Exact match
  Age group, No. (%), y                                                                                                                                                  
  45-64                                                                                      2914 (35.8)        2914 (35.8)                                              Exact match
  65-74                                                                                      3424 (42.1)        3424 (42.1)                                              
  ≥75                                                                                        1797 (22.1)        1797 (22.1)                                              
  Insurance premium, No. (%), NT\$[^c^](#zoi190324t1n3){ref-type="table-fn"}                                                                                             
  Fixed premium, dependent, low income                                                       2844 (35.0)        2844 (35.0)                                              Exact match
  \<20 000                                                                                   2335 (28.7)        2335 (28.7)                                              
  ≥20 000                                                                                    2956 (36.3)        2956 (36.3)                                              
  Residence, No. (%)                                                                                                                                                     
  Rural                                                                                      2387 (29.3)        2387 (29.3)                                              Exact match
  Urban                                                                                      5748 (70.7)        5748 (70.7)                                              
  Coronary artery disease, No. (%)                                                                                                                                       
  No                                                                                         6037 (74.2)        6637 (81.6)                                              \<.001
  Yes                                                                                        2098 (25.8)        1498 (18.4)                                              
  Cerebrovascular disease, No. (%)                                                                                                                                       
  No                                                                                         6854 (84.3)        7226 (88.8)                                              \<.001
  Yes                                                                                        1281 (15.7)        909 (11.2)                                               
  Chronic obstructive pulmonary disease, No. (%)                                                                                                                         
  No                                                                                         6152 (75.6)        6797 (83.6)                                              \<.001
  Yes                                                                                        1983 (24.4)        1338 (16.4)                                              
  Diabetes, No. (%)                                                                                                                                                      
  No                                                                                         6334 (77.9)        6675 (82.1)                                              \<.001
  Yes                                                                                        1801 (22.1)        1460 (17.9)                                              
  Chronic kidney disease, No. (%)                                                                                                                                        
  No                                                                                         7421 (91.2)        7618 (93.6)                                              \<.001
  Yes                                                                                        714 (8.8)          517 (6.4)                                                
  Hypertension, No. (%)                                                                                                                                                  
  No                                                                                         4180 (51.4)        4653 (57.2)                                              \<.001
  Yes                                                                                        3955 (48.6)        3482 (42.8)                                              
  Hyperlipidemia, No. (%)                                                                                                                                                
  No                                                                                         5589 (68.7)        6238 (76.7)                                              \<.001
  Yes                                                                                        2546 (31.3)        1897 (23.3)                                              
  Anxiety, No. (%)                                                                                                                                                       
  No                                                                                         6373 (78.3)        7161 (88.0)                                              \<.001
  Yes                                                                                        1762 (21.7)        974 (12.0)                                               
  Depression, No. (%)                                                                                                                                                    
  No                                                                                         7588 (93.3)        7853 (96.5)                                              \<.001
  Yes                                                                                        547 (6.7)          282 (3.5)                                                
  Alcohol-related illness, No. (%)                                                                                                                                       
  No                                                                                         7987 (98.2)        8024 (98.6)                                              .02
  Yes                                                                                        148 (1.8)          111 (1.4)                                                
  Head injury, No. (%)                                                                                                                                                   
  No                                                                                         7570 (93.1)        7757 (95.4)                                              \<.001
  Yes                                                                                        565 (6.9)          378 (4.6)                                                
  Rheumatoid arthritis, No. (%)                                                                                                                                          
  No                                                                                         7936 (97.6)        8019 (98.6)                                              \<.001
  Yes                                                                                        199 (2.4)          116 (1.4)                                                
  Asthma, No. (%)                                                                                                                                                        
  No                                                                                         7226 (88.8)        7416 (91.2)                                              \<.001
  Yes                                                                                        909 (11.2)         719 (8.8)                                                
  Dementia, No. (%)                                                                                                                                                      
  No                                                                                         7041 (86.6)        7361 (90.5)                                              \<.001
  Yes                                                                                        1094 (13.4)        774 (9.5)                                                
  Length of hospital admission, mean (95% CI), d[^d^](#zoi190324t1n4){ref-type="table-fn"}   2.78 (2.52-3.05)   1.83 (1.55-2.09)                                         \<.001

Abbreviation: HL, hearing loss.

Includes sex-, age-, residence-, and insurance premium--matched controls.

Calculated using the χ^2^ or the 2-tailed *t* test. Testing was not necessary for exact matching samples.

US\$1 = NT\$31.2 in 2019.

Indicates admission to a hospital 1 year before the diagnosis of HL.

Dementia Incidence {#H2-7-ZOI190324}
------------------

Of a total of 16 270 participants, 1868 developed dementia during the follow-up period. Among them, 1094 (58.6%) were from the HL group and 774 (41.4%) were from the non-HL group, as shown in the [Figure](#zoi190324f1){ref-type="fig"}. The mean (SD) follow-up interval for all patients was 6.87 (3.36) years, and the total follow-up intervals were 56 432.01 and 55 355.47 person-years for the HL and non-HL groups, respectively ([Table 2](#zoi190324t2){ref-type="table"}). The dementia incidence rates were 19.38 (95% CI, 18.25-20.57) per 1000 person-years in the HL group and 13.98 (95% CI, 13.01-15.00) per 1000 person-years in the non-HL group. Kaplan-Meier analysis of the cumulative incidence of dementia revealed that dementia incidence rates were significantly higher in the HL group than in the non-HL group (*P* \< .001 according to the log-rank test).

![Cumulative Incidence of Dementia by Study Group\
The 8135 patients with hearing loss (HL group) were matched by sex, age, residence, and insurance premium with 8135 individuals without hearing loss (non-HL group).](jamanetwopen-2-e198112-g001){#zoi190324f1}

###### Incidence Rate of Dementia in Taiwan

  Characteristic                                                      No. of Events   Person-Years   Incidence Rate (95% CI)[^a^](#zoi190324t2n1){ref-type="table-fn"}   Multivariate Cox Proportional Hazards Regression Analysis                                                  
  ------------------------------------------------------------------- --------------- -------------- ------------------------------------------------------------------- ----------------------------------------------------------- ------------------ ------------------ -------- --------
  Hearing loss                                                                                                                                                                                                                                                                      
  No                                                                  774             55 355.47      13.98 (13.01-15.00)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .001     .003
  Yes                                                                 1094            56 432.01      19.38 (18.25-20.57)                                                 1.38 (1.26-1.51)                                            1.17 (1.07-1.29)                               
  Sex                                                                                                                                                                                                                                                                               
  Male                                                                1114            63 589.56      17.52 (16.50-18.58)                                                 1.12 (1.02-1.23)                                            .02                0.90 (0.81-0.99)   .04      .06
  Female                                                              754             48 197.93      15.64 (14.55-16.80)                                                 1 \[Reference\]                                             1 \[Reference\]                                
  Age[^c^](#zoi190324t2n3){ref-type="table-fn"}                       NA              NA             NA                                                                  2.66 (2.53-2.79)                                            \<.001             2.55 (2.42-2.69)   \<.001   \<.001
  Insurance premium, NT\$[^d^](#zoi190324t2n4){ref-type="table-fn"}                                                                                                                                                                                                                 
  Fixed premium, dependent, low income                                644             39 232.14      16.41 (15.17-17.73)                                                 1 \[Reference\]                                             NA                 1 \[Reference\]    NA       NA
  \<20 000                                                            749             31 658.65      23.66 (21.99-25.42)                                                 1.46 (1.31-1.62)                                            \<.001             0.97 (0.87-1.09)   .72      .70
  ≥20 000                                                             475             40 896.70      11.61 (10.59-14.43)                                                 0.71 (0.63-0.80)                                            \<.001             0.71 (0.62-0.81)   \<.001   \<.001
  Residence                                                                                                                                                                                                                                                                         
  Rural                                                               557             32 953.09      16.90 (15.52-18.37)                                                 1 \[Reference\]                                             .77                1 \[Reference\]    .03      .05
  Urban                                                               1311            78 834.39      16.62 (15.74-17.55)                                                 0.99 (0.89-1.09)                                            0.88 (0.78-0.99)                               
  Coronary artery disease                                                                                                                                                                                                                                                           
  No                                                                  1275            90 304.39      14.11 (13.35-14.92)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .001     .01
  Yes                                                                 593             21 483.09      27.60 (25.43-29.92)                                                 2.16 (1.96-2.38)                                            1.16 (1.04-1.29)                               
  Cerebrovascular disease                                                                                                                                                                                                                                                           
  No                                                                  1441            99 009.76      14.55 (13.81-15.32)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                 427             12 777.72      33.41 (30.32-36.74)                                                 2.51 (2.25-2.79)                                            1.36 (1.21-1.52)                               
  Chronic obstructive pulmonary disease                                                                                                                                                                                                                                             
  No                                                                  1346            91384.42       14.73 (13.95-15.54)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .62      .70
  Yes                                                                 522             20 403.06      25.58 (23.44-27.88)                                                 1.88 (1.70-2.08)                                            0.97 (0.87-1.09)                               
  Diabetes                                                                                                                                                                                                                                                                          
  No                                                                  1388            92 053.95      15.07 (14.30-15.89)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                 480             19 733.53      24.32 (22.20-26.60)                                                 1.76 (1.58-1.95)                                            1.29 (1.15-1.44)                               
  Chronic kidney disease                                                                                                                                                                                                                                                            
  No                                                                  1675            104 670.24     16.00 (15.25-16.79)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .67      .70
  Yes                                                                 193             7117.25        27.12 (23.43-31.22)                                                 1.86 (1.60-2.16)                                            1.03 (0.89-1.21)                               
  Hypertension                                                                                                                                                                                                                                                                      
  No                                                                  788             65 581.22      12.02 (11.19-12.88)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .09      .13
  Yes                                                                 1080            46 206.27      23.37 (22.00-24.81)                                                 2.16 (1.97-2.37)                                            1.09 (0.99-1.21)                               
  Hyperlipidemia                                                                                                                                                                                                                                                                    
  No                                                                  1357            84 850.46      15.99 (15.15-16.87)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .63      .70
  Yes                                                                 511             26 937.03      18.97 (17.36-20.69)                                                 1.31 (1.18-1.45)                                            0.97 (0.87-1.09)                               
  Anxiety                                                                                                                                                                                                                                                                           
  No                                                                  1473            95 029.25      15.50 (14.72-16.31)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                 395             16 758.24      23.57 (21.30-26.01)                                                 1.65 (1.47-1.84)                                            1.28 (1.13-1.45)                               
  Depression                                                                                                                                                                                                                                                                        
  No                                                                  1715            106 903.03     16.04 (15.29-16.82)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                 153             4884.45        31.32 (26.56-36.70)                                                 2.12 (1.80-2.50)                                            1.50 (1.25-1.79)                               
  Alcohol-related illness                                                                                                                                                                                                                                                           
  No                                                                  1833            110 306.72     16.61 (15.87-17.40)                                                 1 \[Reference\]                                             .01                1 \[Reference\]    .002     .004
  Yes                                                                 35              1480.76        23.64 (16.46-32.87)                                                 1.55 (1.11-2.17)                                            1.71 (1.22-2.41)                               
  Head injury                                                                                                                                                                                                                                                                       
  No                                                                  1717            106 006.29     16.20 (15.44-16.98)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .001     .003
  Yes                                                                 151             5781.19        26.12 (22.12-30.63)                                                 1.70 (1.44-2.01)                                            1.33 (1.12-1.57)                               
  Rheumatoid arthritis                                                                                                                                                                                                                                                              
  No                                                                  1819            109 880.12     16.55 (15.80-17.33)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    .07      .10
  Yes                                                                 49              1907.37        25.69 (19.01-33.96)                                                 1.69 (1.27-2.25)                                            1.31 (0.98-1.74)                               
  Asthma                                                                                                                                                                                                                                                                            
  No                                                                  1648            102 001.40     16.16 (15.39-16.96)                                                 1 \[Reference\]                                             \<.001             1 \[Reference\]    \>.99    \>.99
  Yes                                                                 220             9786.08        22.48 (19.61-25.66)                                                 1.51 (1.31-1.74)                                            1.00 (0.86-1.16)                               
  Length of hospital stay[^e^](#zoi190324t2n5){ref-type="table-fn"}   NA              NA             NA                                                                  1.58 (1.30-1.91)                                            \<.001             1.26 (0.90-1.77)   .18      .25

Abbreviations: FDR, false discovery rate; HR, hazard ratio; NA, not applicable.

Indicates per 1000 person-years.

Adjusted for sex, age, residence, insurance premium, coronary artery disease, chronic obstructive pulmonary disease, cerebrovascular disease, diabetes, chronic kidney disease, hypertension, hyperlipidemia, anxiety, depression, alcohol-related illness, head injury, rheumatoid arthritis, asthma, and length of hospital stay.

Indicates mean age at date of diagnosis of hearing loss divided by 10.

US\$1 = NT\$31.2 in 2019.

Indicates number of admission days divided by 100.

HL and the Risk of Dementia {#H2-8-ZOI190324}
---------------------------

As shown in [Table 2](#zoi190324t2){ref-type="table"}, a high rate of dementia incidence (\>20.00 per 1000 person-years) was found in patients with cerebrovascular disease, coronary artery disease, chronic obstructive pulmonary disease, diabetes, chronic kidney disease, hypertension, anxiety, depression, alcohol-related illnesses, head injury, rheumatoid arthritis, and asthma compared with patients without these conditions. In the fully adjusted multivariate Cox proportional hazards regression model for risk analysis, HL was positively associated with dementia (HR, 1.17; 95% CI, 1.07-1.29; FDR *P* = .003). Advanced age (HR, 2.55; 95% CI, 2.42-2.69; FDR *P* \< .001) was significantly and positively associated with dementia; however, a high insurance premium (HR, 0.71; 95% CI, 0.62-0.81; FDR *P* \< .001) was significantly and negatively associated with dementia. Moreover, cerebrovascular disease (HR, 1.36; 95% CI, 1.21-1.52), diabetes (HR, 1.29; 95% CI, 1.15-1.44), anxiety (HR, 1.28; 95% CI, 1.13-1.45), depression (HR, 1.50; 95% CI, 1.25-1.79), alcohol-related illnesses (HR, 1.71; 95% CI, 1.22-2.41), and head injury (HR, 1.33; 95% CI, 1.12-1.57) were significantly and positively associated with dementia (FDR *P* \< .01 for all) according to the fully adjusted multivariate Cox proportional hazards regression model for risk analysis. Subgroup analysis by sex and age groups (eTable in the [Supplement](#note-ZOI190324-1-s){ref-type="supplementary-material"}) indicated that male sex was significantly and positively associated with dementia (HR, 1.20; 95% CI, 1.06-1.36; FDR *P* = .008) and that the group aged 45 to 64 years was positively associated with dementia (HR, 2.21; 95% CI, 1.57-3.12; FDR *P* \< .001).

Sensitivity and Subgroup Analyses {#H2-9-ZOI190324}
---------------------------------

The distributions of potential confounders were similar between the HL and non-HL groups after propensity score matching (standardized difference, \<0.1) ([Table 3](#zoi190324t3){ref-type="table"}). The results obtained from sensitivity analysis ([Table 4](#zoi190324t4){ref-type="table"}) were applied to the fully adjusted Cox proportional hazards regression model, which revealed a nonsignificant association between HL and dementia risk (HR, 1.11; 95% CI, 1.01-1.22; FDR *P* = .051). Advanced age (HR, 2.49; 95% CI, 2.36-2.62), cerebrovascular disease (HR, 1.26; 95% CI, 1.12-1.41), diabetes (HR, 1.32; 95% CI, 1.19-1.47), anxiety (HR, 1.28; 95% CI, 1.14-1.44), depression (HR, 1.62; 95% CI, 1.37-1.91), and head injury (HR, 1.27; 95% CI, 1.08-1.49) were significantly and positively associated with dementia (FDR *P* \< .01 for all), and the highest insurance premium was significantly and negatively associated with dementia (HR, 0.69; 95% CI, 0.61-0.79; FDR *P* \< .001). These findings were similar to the results of our main analysis. Subgroup analyses revealed that, among the 3 age groups (eTable in the [Supplement](#note-ZOI190324-1-s){ref-type="supplementary-material"}), the group aged 45 to 64 years was associated with a significant risk of dementia (HR, 1.40; 95% CI, 1.12-1.75; FDR *P* = .01). Male sex was not associated with a significant risk of dementia. Segment-adjusted analysis showed that HL was not significantly associated with dementia 1 to 4 years after the index date (HR, 1.17; 95% CI, 1.02-1.35; FDR *P* = .06). The association was significant 5 to 12 years after the index date (HR, 1.17; 95% CI, 1.04-1.33; FDR *P* = .04) in exact matching analysis; the association between HL and dementia 1 to 4 years after the index date (HR, 1.07; 95% CI, 0.94-1.23; FDR *P* = .39) and the association 5 to 12 years after the index date (HR, 1.15; 95% CI, 1.01-1.30; FDR *P* = .07) in propensity score matching analysis were not significant.

###### Demographic and Clinical Characteristics of the Study Population Based on HL Diagnosis and Propensity Score Matching

  Characteristic                                                      Before Matching[^a^](#zoi190324t3n1){ref-type="table-fn"}   After Matching[^a^](#zoi190324t3n1){ref-type="table-fn"}                                      
  ------------------------------------------------------------------- ----------------------------------------------------------- ---------------------------------------------------------- ------ ------------- ------------- -------------
  Sex                                                                                                                                                                                                                           
  Male                                                                4643 (57.1)                                                 453 663 (49.4)                                             0.15   4643 (57.1)   4461 (54.8)   0.04
  Female                                                              3492 (42.9)                                                 464 884 (50.6)                                             0.15   3492 (42.9)   3674 (45.2)   0.04
  Age group, y                                                                                                                                                                                                                  
  45-64                                                               3960 (48.7)                                                 846 742 (92.2)                                             1.08   3960 (48.7)   3772 (46.4)   0.05
  65-74                                                               2378 (29.2)                                                 45 997 (5.0)                                               0.68   2378 (29.2)   2335 (28.7)   0.01
  ≥75                                                                 1797 (22.1)                                                 25 808 (2.8)                                               0.61   1797 (22.1)   2028 (24.9)   0.07
  Insurance premium, NT\$[^b^](#zoi190324t3n2){ref-type="table-fn"}                                                                                                                                                             
  Fixed premium, dependent, low income                                2844 (35.0)                                                 293 091 (31.9)                                             0.06   2844 (35.0)   3136 (38.5)   0.07
  \<20 000                                                            2335 (28.7)                                                 196 648 (21.4)                                             0.17   2335 (28.7)   2201 (27.1)   0.04
  ≥20 000                                                             2956 (36.3)                                                 428 808 (46.7)                                             0.21   2956 (36.3)   2798 (34.4)   0.04
  Residence                                                                                                                                                                                                                     
  Rural                                                               2387 (29.3)                                                 190 897 (20.8)                                             0.20   2387 (29.3)   2385 (29.3)   0.0004
  Urban                                                               5748 (70.7)                                                 727 650 (79.2)                                             0.20   5748 (70.7)   5750 (70.7)   0.0004
  Index year                                                                                                                                                                                                                    
  2000                                                                890 (10.9)                                                  83 336 (9.1)                                               0.06   890 (10.9)    890 (10.94)   Exact match
  2001                                                                853 (10.5)                                                  81 582 (8.9)                                               0.05   853 (10.5)    853 (10.5)    Exact match
  2002                                                                812 (10.0)                                                  80 823 (8.8)                                               0.04   812 (10.0)    812 (10.0)    Exact match
  2003                                                                754 (9.3)                                                   80 773 (8.8)                                               0.02   754 (9.3)     754 (9.3)     Exact match
  2004                                                                815 (10.0)                                                  79 627 (8.7)                                               0.05   815 (10.0)    815 (10.0)    Exact match
  2005                                                                754 (9.3)                                                   77 122 (8.4)                                               0.03   754 (9.3)     754 (9.3)     Exact match
  2006                                                                687 (8.4)                                                   75 121 (8.2)                                               0.01   687 (8.4)     687 (8.4)     Exact match
  2007                                                                628 (7.7)                                                   74 109 (8.1)                                               0.01   628 (7.7)     628 (7.7)     Exact match
  2008                                                                603 (7.4)                                                   72 967 (7.9)                                               0.02   603 (7.4)     603 (7.4)     Exact match
  2009                                                                558 (6.9)                                                   71 568 (7.8)                                               0.04   558 (6.9)     558 (6.9)     Exact match
  2010                                                                459 (5.6)                                                   70 843 (7.7)                                               0.08   459 (5.6)     459 (5.6)     Exact match
  2011                                                                322 (4.0)                                                   69 891 (7.6)                                               0.16   322 (4.0)     322 (4.0)     Exact match
  Coronary artery disease                                                                                                                                                                                                       
  No                                                                  6037 (74.2)                                                 878 706 (95.7)                                             0.63   6041 (74.3)   6252 (76.9)   0.06
  Yes                                                                 2098 (25.8)                                                 39 841 (4.3)                                               0.63   2094 (25.7)   1883 (23.1)   0.06
  Cerebrovascular disease                                                                                                                                                                                                       
  No                                                                  6854 (84.3)                                                 897 336 (97.7)                                             0.48   6854 (84.3)   7092 (87.2)   0.08
  Yes                                                                 1281 (15.7)                                                 21 211 (2.3)                                               0.48   1281 (15.7)   1043 (12.8)   0.08
  Chronic obstructive pulmonary disease                                                                                                                                                                                         
  No                                                                  6152 (75.6)                                                 879 576 (95.8)                                             0.60   6152 (75.6)   6418 (78.9)   0.08
  Yes                                                                 1983 (24.4)                                                 38 971 (4.2)                                               0.60   1983 (24.4)   1717 (21.1)   0.08
  Diabetes                                                                                                                                                                                                                      
  No                                                                  6334 (77.9)                                                 869 840 (94.7)                                             0.50   6334 (77.9)   6457 (79.4)   0.04
  Yes                                                                 1801 (22.1)                                                 48 707 (5.3)                                               0.50   1801 (22.1)   1678 (20.6)   0.04
  Chronic kidney disease                                                                                                                                                                                                        
  No                                                                  7421 (91.2)                                                 901 083 (98.1)                                             0.31   7421 (91.2)   7544 (92.7)   0.06
  Yes                                                                 714 (8.8)                                                   17 464 (1.9)                                               0.31   714 (8.8)     591 (7.3)     0.06
  Hypertension                                                                                                                                                                                                                  
  No                                                                  4180 (51.4)                                                 812 283 (88.4)                                             0.88   4180 (51.4)   4214 (51.8)   0.01
  Yes                                                                 3955 (48.6)                                                 106 264 (11.6)                                             0.88   3955 (48.6)   3921 (48.2)   0.01
  Hyperlipidemia                                                                                                                                                                                                                
  No                                                                  5589 (68.7)                                                 841 754 (91.6)                                             0.60   5589 (68.7)   5722 (70.3)   0.04
  Yes                                                                 2546 (31.3)                                                 76 793 (8.4)                                               0.60   2546 (31.3)   2413 (29.7)   0.04
  Anxiety                                                                                                                                                                                                                       
  No                                                                  6373 (78.3)                                                 867 351 (94.4)                                             0.48   6373 (78.3)   6559 (80.6)   0.06
  Yes                                                                 1762 (21.7)                                                 51 196 (5.6)                                               0.48   1762 (21.7)   1576 (19.4)   0.06
  Depression                                                                                                                                                                                                                    
  No                                                                  7588 (93.3)                                                 900 005 (98.0)                                             0.23   7588 (93.3)   7705 (94.7)   0.06
  Yes                                                                 547 (6.7)                                                   18 542 (2.0)                                               0.23   547 (6.7)     430 (5.3)     0.06
  Alcohol-related illness                                                                                                                                                                                                       
  No                                                                  7987 (98.2)                                                 911 467 (99.2)                                             0.09   7987 (98.2)   8001 (98.4)   0.01
  Yes                                                                 148 (1.8)                                                   7080 (0.8)                                                 0.09   148 (1.8)     134 (1.6)     0.01
  Head injury                                                                                                                                                                                                                   
  No                                                                  7570 (93.1)                                                 888 807 (96.8)                                             0.17   7570 (93.1)   7661 (94.2)   0.05
  Yes                                                                 565 (6.9)                                                   29 740 (3.2)                                               0.17   565 (6.9)     474 (5.8)     0.05
  Rheumatoid arthritis                                                                                                                                                                                                          
  No                                                                  7936 (97.6)                                                 913 285 (99.4)                                             0.15   7936 (97.6)   7975 (98.0)   0.03
  Yes                                                                 199 (2.4)                                                   5262 (0.6)                                                 0.15   199 (2.4)     160 (2.0)     0.03
  Asthma                                                                                                                                                                                                                        
  No                                                                  7226 (88.8)                                                 866 717 (94.4)                                             0.20   7226 (88.8)   7329 (90.1)   0.04
  Yes                                                                 909 (11.2)                                                  51 830 (5.6)                                               0.20   909 (11.2)    806 (9.9)     0.04
  Admission[^c^](#zoi190324t3n3){ref-type="table-fn"}                                                                                                                                                                           
  No                                                                  6132 (75.4)                                                 856 284 (93.2)                                             0.42   6132 (75.4)   6356 (78.1)   0.06
  Yes                                                                 2003 (24.6)                                                 62 263 (6.8)                                               0.42   2003 (24.6)   1779 (21.9)   0.06

Abbreviation: HL, hearing loss.

Propensity score matching was performed for sex, age, residence, insurance premium, coronary artery disease, chronic obstructive pulmonary disease, cerebrovascular disease, diabetes, chronic kidney disease, hypertension, hyperlipidemia, anxiety, depression, alcohol-related illness, head injury, rheumatoid arthritis, asthma, times of hospital admission, and index year.

US\$1 = NT\$31.2 in 2019.

Indicates admission to a hospital 1 year before a diagnosis of HL.

###### Propensity Score Matching to Reveal the Association Between Clinical Characteristics and Dementia Risk in Taiwan

  Characteristic                                                         All Participants (n = 16 270)                                                  
  ---------------------------------------------------------------------- ------------------------------- ------------------ ------------------ -------- --------
  Hearing loss                                                                                                                                          
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .02      .051
  Yes                                                                    1.18 (1.08-1.29)                1.11 (1.01-1.22)                               
  Sex                                                                                                                                                   
  Male                                                                   1.10 (1.00-1.20)                .04                1.02 (0.92-1.12)   .71      .79
  Female                                                                 1 \[Reference\]                 1 \[Reference\]                                
  Age[^b^](#zoi190324t4n2){ref-type="table-fn"}                          2.55 (2.43-2.67)                \<.001             2.49 (2.36-2.62)   \<.001   \<.001
  Insurance premium, NT\$[^c^](#zoi190324t4n3){ref-type="table-fn"}                                                                                     
  Fixed premium, dependent, low income                                   1 \[Reference\]                 NA                 1 \[Reference\]    NA       NA
  \<20 000                                                               1.25 (1.12-1.38)                \<.001             0.89 (0.80-0.99)   .06      .70
  ≥20 000                                                                0.67 (0.60-0.75)                \<.001             0.69 (0.61-0.79)   \<.001   \<.001
  Residence                                                                                                                                             
  Rural                                                                  1 \[Reference\]                 .45                1 \[Reference\]    .08      .13
  Urban                                                                  0.96 (0.87-1.06)                0.91 (0.81-1.01)                               
  Coronary artery disease                                                                                                                               
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .32      .38
  Yes                                                                    1.99 (1.81-2.19)                1.05 (0.95-1.17)                               
  Cerebrovascular disease                                                                                                                               
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                    2.39 (2.15-2.66)                1.26 (1.12-1.41)                               
  Chronic obstructive pulmonary disease                                                                                                                 
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .87      .87
  Yes                                                                    1.81 (1.64-1.99)                1.01 (0.91-1.12)                               
  Diabetes                                                                                                                                              
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                    1.75 (1.59-1.94)                1.32 (1.19-1.47)                               
  Chronic kidney disease                                                                                                                                
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .87      .87
  Yes                                                                    1.89 (1.63-2.19)                1.01 (0.87-1.18)                               
  Hypertension                                                                                                                                          
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .03      .05
  Yes                                                                    2.17 (1.98-2.38)                1.12 (1.01-1.24)                               
  Hyperlipidemia                                                                                                                                        
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .09      .13
  Yes                                                                    1.32 (1.20-1.45)                1.10 (0.99-1.22)                               
  Anxiety                                                                                                                                               
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                    1.50 (1.35-1.67)                1.28 (1.14-1.44)                               
  Depression                                                                                                                                            
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    \<.001   \<.001
  Yes                                                                    2.06 (1.77-2.40)                1.62 (1.37-1.91)                               
  Alcohol-related illness                                                                                                                               
  No                                                                     1 \[Reference\]                 .10                1 \[Reference\]    .09      .13
  Yes                                                                    1.32 (0.94-1.84)                1.34 (0.96-1.88)                               
  Head injury                                                                                                                                           
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .004     .01
  Yes                                                                    1.55 (1.32-1.82)                1.27 (1.08-1.49)                               
  Rheumatoid arthritis                                                                                                                                  
  No                                                                     1 \[Reference\]                 .01                1 \[Reference\]    .27      .33
  Yes                                                                    1.44 (1.08-1.91)                1.17 (0.88-1.56)                               
  Asthma                                                                                                                                                
  No                                                                     1 \[Reference\]                 \<.001             1 \[Reference\]    .22      .28
  Yes                                                                    1.65 (1.44-1.88)                1.09 (0.95-1.26)                               
  Length of hospital stay, d[^d^](#zoi190324t4n4){ref-type="table-fn"}   1.25 (1.14-1.37)                \<.001             1.26 (1.11-1.42)   \<.001   \<.001

Abbreviations: FDR, false discovery rate; HR, hazard ratio; NA, not applicable.

Adjusted for sex, age, residence, insurance premium, coronary artery disease, chronic obstructive pulmonary disease, cerebrovascular disease, diabetes, chronic kidney disease, hypertension, hyperlipidemia, anxiety, depression, alcohol-related illnesses, head injury, rheumatoid arthritis, asthma, length of hospital stay, and outpatient visits.

Indicates mean age at date of diagnosis of hearing loss, divided by 10.

US\$1 = NT\$31.2 in 2019.

Indicates number of admission days divided by 100.

In the group aged 45 to 64 years, the interactions between head injury and HL (Wald χ^2^~1~ test, 2.19; *P* = .14) or between alcohol-related illness and HL (Wald χ^2^~1~ test, 0.08; *P* = .77) were not significant. In the group aged 65 to 74 years, the interaction between head injury and HL was significant (Wald χ^2^~1~ test, 4.48; *P* = .03), and the interaction between alcohol-related illness and HL was not significant (Wald χ^2^~1~ test, 0.98; *P* = .32). In the group aged 75 years or older, the interactions between head injury and HL (Wald χ^2^~1~ test, 1.29; *P* = .25) or between alcohol-related illness and HL (Wald χ^2^~1~ test, 0.86; *P* = .35) were not significant.

Discussion {#H1-4-ZOI190324}
==========

The findings of the present population-based cohort study indicate that HL is positively associated with the risk of dementia. These results were robust after adjustments for multiple confounders, and patients with HL had a significantly higher risk of dementia. Subgroup analyses revealed that, among the 3 age groups, the group aged 45 to 64 years was associated with a significant risk of dementia.

The main analysis results demonstrated that in the HL group, patients aged 45 to 64 years showed significantly stronger and more positive associations with dementia occurrence than patients aged 65 to 74 years or 75 years or older compared with their counterparts in the non-HL group. Patients with HL aged 45 to 64 years were characterized by a higher HR, whereas similar findings were not obtained for patients aged 65 to 74 years or 75 years or older. Previous studies^[@zoi190324r3],[@zoi190324r4]^ have indicated that age-related HL, such as presbycusis and sensory HL,^[@zoi190324r2],[@zoi190324r7],[@zoi190324r9],[@zoi190324r15]^ is associated with the incidence of dementia and even development of Alzheimer disease (AD). However, scant evidence suggests an increased risk of dementia or AD in middle-aged patients with HL, and this research topic has received little attention previously. Recently, Livingston et al^[@zoi190324r12]^ observed that preventing HL in midlife may modify the 9.1% risk of incident dementia. A recent cohort study^[@zoi190324r16]^ reported that midlife HL is associated with an increased rate of dementia at younger than 60 years, and the association between HL and cognition may be due to shared etiology or because HL causes cognitive reduction through impaired speech perception in younger individuals and increased use of executive function and working memory in older people, resulting in the constant effort. These findings support the association between midlife HL and dementia.

Several neural changes have been described in people with hearing impairment. Age-related HL may result in the acceleration of aging because the peripheral and central nervous systems can alter synapses and neural anatomy with aging.^[@zoi190324r17]^ To compensate for decreased auditory input owing to HL, increased listening effort is required through the additional recruitment of frontal areas.^[@zoi190324r18]^ An increase in cognitive load occurs in patients who are hard of hearing; consequently, cognitive processes such as memory and executive function are adversely affected.^[@zoi190324r19],[@zoi190324r20]^ Hearing loss, defined as sensory deprivation, may alter the usual pattern of resource allocation in the brain, thereby affecting neural reserves and cognitive performance.^[@zoi190324r20],[@zoi190324r21]^ Hearing loss leads to altered auditory processing, and research has shown that cross-modal neuroplasticity changes in the auditory cortex and altered visual and audiovisual information processing affect functional connectivity between the sensory cortices.^[@zoi190324r18],[@zoi190324r19],[@zoi190324r22]^ Hence, early HL development may causally accelerate atrophy in the entire brain, which could lead to cognitive reserve depletion in the brain.^[@zoi190324r23]^

Hearing loss is associated with difficulties in understanding speech, especially under adverse listening conditions,^[@zoi190324r24]^ and patients with HL may experience long-term disturbances in life, such as difficulties in communication, social isolation, and bad mood, which further suggests that HL may be associated with dementia.^[@zoi190324r25]^ Intervention studies have indicated that hearing aids are associated with higher cognitive performance, and this association is mediated through social isolation or depression. Higher levels of HL are associated with an increased risk of social isolation,^[@zoi190324r26],[@zoi190324r27]^ and social isolation and depression have been found to exacerbate cognitive impairment.^[@zoi190324r28]^

Hearing loss is a potential reversible risk factor for dementia and AD.^[@zoi190324r12],[@zoi190324r17],[@zoi190324r29]^ Studies^[@zoi190324r30],[@zoi190324r31]^ have demonstrated that hearing aids and cochlear implants impede cognitive decline. Hence, the early identification of HL in patients and successful hearing rehabilitation can mitigate the negative effects of HL.^[@zoi190324r12]^ However, the ideal time to perform HL screening to reduce the risk of dementia remains unclear. The findings of the present study suggest that screening for HL should be performed when people are middle aged.

In the present study, 6 comorbidities were significantly associated with an increased risk of dementia (FDR *P* \< .01) in fully adjusted analysis, namely, cerebrovascular disease, diabetes, anxiety, depression, alcohol-related illnesses, and head injury. This finding implies a strong association between these comorbidities and dementia risk. An increasing number of studies have reported that cerebrovascular disease, diabetes, anxiety, depression, and head injury are risk factors for dementia, and these conditions might interrupt cognitive reserve function (as discussed previously)^[@zoi190324r12]^; however, alcohol-related illnesses did not show such an association. Chronic alcoholism adversely affects the brain, causing cognitive impairment.^[@zoi190324r32],[@zoi190324r33]^ A study indicated that alcohol use--related disorders are associated with a significantly higher risk of dementia.^[@zoi190324r34]^ Other studies have shown that frequent alcohol consumption is associated with an increased risk of dementia compared with infrequent alcohol consumption.^[@zoi190324r35]^ However, a systematic review^[@zoi190324r36]^ indicated that light to moderate alcohol consumption may protect against AD and dementia. This discrepancy may be due to the case definition. That study included patients with confirmed diagnoses related to alcoholism, and previous studies have included patients based on self-report drinking behavior questionnaires.

Strengths and Limitations {#H2-10-ZOI190324}
-------------------------

This cohort study was based on nationwide representative data, and potential confounders such as social and demographic factors and the general health status were controlled for in the adjusted multivariate Cox proportional hazards regression models in the main analysis and through propensity score matching in the sensitivity analysis. However, the principal limitation with any study of this nature is that causality is difficult to infer, and we can only state that findings support a given hypothesis. In addition, the main limitation of studies based on the insurance database is the lack of precision in dementia diagnosis. Moreover, the database contains limited or no information on other potential confounders such as educational level, body mass index, physical activities, diet pattern, blood pressure, blood glucose levels, smoking, and use of hearing aids. Information on dementia subtype and HL severity is also lacking in the study database. Disease onset and diagnosis may differ according to the economic status and residence of patients because these variables affect access to neurologists. The comorbidity rate in patients with HL was higher than that in the non-HL group; patients with HL are possibly diagnosed with dementia earlier due to frequent outpatient visits. The HL group might have more opportunities for dementia diagnoses than the non-HL group. We used propensity score matching in sensitivity analysis to address this potential bias. Our segment analysis showed that the association of HL with dementia was significant at 5 to 12 years and not at 1 to 4 years after the index date of HL. Therefore, this bias was weak in our study. Despite the limitations of this study, the association between HL and dementia was consistent with many other investigations in the literature.^[@zoi190324r2],[@zoi190324r3],[@zoi190324r12]^

Conclusions {#H1-5-ZOI190324}
===========

In this cohort study, HL was associated with a significant increase in the risk of dementia, especially in patients aged 45 to 64 years. This finding suggests that the implementation of early hearing protection, HL screening, and the use of hearing aids may help to mitigate this potential risk factor for dementia.

###### 

**eFigure 1.** Flowchart of Database Assembly and Cohort Study Cases Selection

**eFigure 2.** Age Distribution in Non--Hearing Loss and Hearing Loss Groups

**eTable.** Effect of Hearing Loss on Dementia in Taiwan by Sex and Age Groups, Cohort Study, 2000 to 2011
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Click here for additional data file.
